Literature DB >> 34011417

Efficacy of relatively low-cost ultraviolet-C light devices against Candida auris.

Basya S Pearlmutter1, Muhammed F Haq1, Jennifer L Cadnum1, Annette L Jencson1, Matthew Carlisle1, Curtis J Donskey2,3.   

Abstract

BACKGROUND: Ultraviolet-C (UV-C) light devices could be useful to reduce environmental contamination with Candida auris. However, variable susceptibility of C. auris strains to UV-C has been reported, and the high cost of many devices limits their use in resource-limited settings.
OBJECTIVE: To evaluate the efficacy of relatively low-cost (<$15,000 purchase price) UV-C devices against C. auris strains from the 4 major phylogenetic clades.
METHODS: A modification of the American Society for Testing and Materials (ASTM) standard quantitative disk carrier test method (ASTM E 2197) was used to examine and compare the effectiveness of UV-C devices against C. auris, methicillin-resistant Staphylococcus aureus (MRSA), and bacteriophage Phi6. Reductions of 3 log10 were considered effective. UV-C irradiance measurements and colorimetric indicators were used to assess UV-C output.
RESULTS: Of 8 relatively low-cost UV-C devices, 6 met the criteria for effective decontamination of C. auris isolates from clades I and II, MRSA, and bacteriophage Phi6, including 3 room decontamination devices and 3 UV-C box devices. Candida auris isolates from clades III and IV were less susceptible to UV-C than clade I and II isolates; 1 relatively low-cost room decontamination device and 2 enclosed box devices met the criteria for effective decontamination of clade III and IV isolates. UV-C irradiance measurements and colorimetric indicator results were consistent with microorganism reductions.
CONCLUSIONS: Some relatively low-cost UV-C light technologies are effective against C. auris, including isolates from clades III and IV with reduced UV-C susceptibility. Studies are needed to evaluate the effectiveness of UV-C devices in clinical settings.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34011417     DOI: 10.1017/ice.2021.206

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   6.520


  1 in total

1.  Public health issues with Candida auris in COVID-19 patients.

Authors:  Edmund J Janniger; Rajendra Kapila
Journal:  World Med Health Policy       Date:  2021-09-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.